Modern Chinese Medicine Group Co., Ltd.
HKSE: 1643.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Hongli Zhang
- Employees
- 190
- Headquarters
- Chengde, China
- IPO year
- 2021
- Market cap
- HK$2.2B
- Website
- https://www.cdysjdyy.com
Loading 1643…
Loading profile data…Frequently asked questions about 1643
What does Modern Chinese Medicine Group Co., Ltd. (1643.HK) do?
Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China. It offers therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, respiratory system, and ner...
Where does 1643.HK trade?
Modern Chinese Medicine Group Co., Ltd. (1643.HK) trades on the Hong Kong Stock Exchange.
What sector is 1643.HK in?
Modern Chinese Medicine Group Co., Ltd. (1643.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Modern Chinese Medicine Group Co., Ltd.?
Hongli Zhang is the chief executive officer of Modern Chinese Medicine Group Co., Ltd. (1643.HK).
Where is Modern Chinese Medicine Group Co., Ltd. headquartered?
Modern Chinese Medicine Group Co., Ltd. is headquartered in China.
Does 1643.HK pay a dividend?
Modern Chinese Medicine Group Co., Ltd. (1643.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 1643.HK go public?
Modern Chinese Medicine Group Co., Ltd. (1643.HK) completed its initial public offering in 2021.